Terumo Aortic Launches RelayPro Thoracic Stent Graft System in Europe

Terumo Aortic has announced the European limited market release of the RelayPro Thoracic Stent-Graft System. RelayPro is a low profile, next-generation device designed to expand the treatment of thoracic endovascular aortic repair (TEVAR) to patients with smaller access vessels. Utilizing the same stent design, material, and Dual Sheath Technology of the RelayPlus with a 3 to 4 Fr reduction in outer profile, RelayPro delivers the accuracy, control and confidence of the RelayPlus without compromising device integrity and durability.
 
RelayPro offers physicians a wide range of diameters, lengths, tapers, and proximal configurations. Available in both Bare Stent and Non-Bare Stent (NBS) versions, RelayPro can be individualized to meet the specific anatomical needs of patients.
 
Mark Miles, global vice president of Marketing at Terumo Aortic, said, “By combining the stent design and material of RelayPlus with a lower outer profile, RelayPro enables percutaneous access to treat a larger patient population. This advancement not only expands patient applicability but will help improve access site complications and ultimately reduce the burden of rising global healthcare costs.”
 
RelayPro is currently enrolling in multiple trials in the United States and Japan for treatment of descending thoracic aortic aneurysms, acute complicated Type B thoracic aortic dissection, and blunt aortic trauma.
 
Terumo has combined Bolton Medical and Vascutek to power a dedicated approach focused on aortic innovation. With locations in Glasgow, Scotland and Sunrise, Fla., the integrated company offers advanced technologies such as surgical grafts, hybrid grafts and catheter-based stent graft systems to meet the unique needs of each patient and transform the treatment of aortic disease. Vascutek and Bolton Medical are both subsidiaries of the Terumo Corporation of Japan, a global medical device company which was founded in 1921 and currently has over 22,000 employees worldwide. Terumo acquired Vascutek in 2002 and Bolton Medical in 2017. Vascutek has 800 employees and Bolton Medical has 300.